Blog: Can AI-Clinician Collaboration Improve Medical Care?
AI-clinician collaboration can improve medical care when machines extend pattern recognition and clinicians preserve context, verification, and accountability. Evidence suggests that combined performance can improve in defined tasks, but poor advice,…
Texas Hemp Ban Compliance in 2026: Implications for Patients and Clinicians
The 2026 Texas hemp ban compliance debate highlights safety and access concerns for patients using hemp-derived THC products. Lawmakers aim to reduce child exposure and poison-control incidents. Patients and clinicians must understand the evolving…
GLP-1 Receptor Agonist Safety: Counterfeit Drug Risks
Counterfeit GLP-1 medications present serious safety risks including inconsistent dosing and contamination. These unauthorized products can cause adverse events and treatment failures. Clinicians must counsel patients on obtaining GLP-1 drugs from…
Cannabis Edibles and Alcohol Create Synergistic Driving Impairment
A recent study reveals that cannabis edibles and alcohol produce synergistic impairment that exceeds the combined effects of either substance used alone. This finding has significant implications for patient counseling, as clinicians must warn patients…
Fewer Than 1 in 5 Older Adults Discuss Cannabis Use With Clinicians
A recent study reveals that fewer than 20% of older adults disclose their cannabis use to healthcare providers, creating a significant communication gap. This silence prevents clinicians from assessing drug interactions and monitoring adverse effects in…
Medical Cannabis Quality Standards vs Street Cannabis Safety
Medical cannabis quality standards ensure patient safety through rigorous testing and pharmaceutical-grade production. Street cannabis lacks these safety protocols, potentially exposing patients to contaminants and inconsistent dosing. Understanding…
Reclassification of marijuana opens doors for much-needed medical research … – The Conversation
The DEA's proposed reclassification of cannabis from Schedule I to Schedule III represents a watershed moment for medical research opportunities in cannabis medicine. This regulatory shift will remove decades-old barriers to rigorous clinical studies…
Industry Publishes New Guidance for Patients Travelling with Medical Cannabis
New industry guidance for medical cannabis travel addresses critical gaps in patient education about legal requirements and safety considerations. These medical cannabis travel guidelines provide essential frameworks for maintaining treatment continuity…
Hampton Roads small businesses react to retail cannabis legislation – The Virginian-Pilot
Virginia's expanding cannabis retail market creates new considerations for patient care and therapeutic oversight. Understanding the differences between medical and retail cannabis programs helps patients make informed decisions about product sourcing…
$1.3M in cannabis seized, two Rochester smoke shops shut down – WROC
Recent enforcement actions against unlicensed cannabis dispensary health risks highlight why patients need regulated sources for therapeutic cannabis. Licensed medical programs provide essential safety standards including contamination testing and…